NEW YORK (GenomeWeb News) - Bioinformatics company GeneGo today said Chang Gung University in Taiwan has upgraded its web license for the company’s MetaCore platform to a permanent installation and has licensed the company’s MapEditor, which is used to draft and edit pathways maps.
The MetaCore 4.1 computation platform is used in the target selection, validation, and identification of biomarkers for disease and drug development.
Chang Gung University will use the GeneGo tools in gene-expression studies, and to compute and map proteomic and metabolomic data and to produce pathway maps for use by the school’s research community.
GeneGo VP Julie Bryant described Taiwan as “an important, fast growing market for us.”
Tri-I Biotech served as a broker for the deal.